Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Ardent Health (ARDT) Acquisitions (2024 - 2025)

Ardent Health has reported Acquisitions over the past 2 years, most recently at $2.5 million for Q4 2025.

Quarterly results put Acquisitions at $2.5 million for Q4 2025, down 90.89% from a year ago — trailing twelve months through Dec 2025 was $2.5 million (down 92.95% YoY), and the annual figure for FY2025 was $2.5 million, down 92.95%.
Acquisitions for Q4 2025 was $2.5 million at Ardent Health, down from $27.5 million in the prior quarter.
Over the last five years, Acquisitions for ARDT hit a ceiling of $27.5 million in Q4 2024 and a floor of $244000.0 in Q3 2024.